Get startedLog in
    Picture of Clearmind Medicine logo

    CMND — Clearmind Medicine News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: Clearmind Medicine Receives IRB Approval For Phase 1/2a Clinical Trial For Alcohol Use Disorder

    Picture of Clearmind Medicine logoClearmind Medicine
    05/08/2025 14:27
    Aug 5 (Reuters) - Clearmind Medicine Inc CMND.O:

CLEARMIND MEDICINE RECEIVES IRB APPROVAL FOR PHASE 1/2A CLINICAL TRIAL FOR ALCOHOL USE DISORDER AT HADASSAH MEDICAL CENTER

CLEARMIND MEDICINE INC - IRB APPROVAL FOLLOWS FDA IND CLEARANCE

Source text: ID:nGNXc3pNHt

Further company coverage: CMND.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Clearmind Medicine

    See all news